510(k) device
ImmunoCAP Specific IgE
Phadia AB · System, Test, Radioallergosorbent (Rast) Immunological (DHB, Class II) · First FDA decision Jul 10, 2013, newest Apr 16, 2018Asthma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
1
Naming "ImmunoCAP Specific IgE"
MAUDE reports
0
Brand "ImmunoCAP Specific IgE", since 2015
PubMed studies
15
Mentioning "ImmunoCAP Specific IgE"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ImmunoCAP Specific IgE
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K173726 · Decided Apr 16, 2018 · 132 days after receipt
Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB) · Laboratory Medicine & Pathology
K150854 · Decided Dec 14, 2015 · 258 days after receipt
Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB) · Laboratory Medicine & Pathology
K131738 · Decided Jul 10, 2013 · 27 days after receipt
Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "ImmunoCAP Specific IgE", any status and sponsor, newest update first.
Abionic SANot on our public-company list
NCT04401631 · 0 participants · Start Nov 2020 · Primary completion Nov 2020
Device: Blood Collection · For: Allergy; Allergic Asthma; Allergy to Cats and 4 more
Sites: Washington D.C., District of Columbia; Baltimore, Maryland; Cincinnati, Ohio
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ImmunoCAP Specific IgE", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code DHB
55 reports: 51 malfunction, 4 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0947-2015 · Started Nov 20, 2014 · Posted by FDA Jan 12, 2015
Reason given: During an investigation of instrument logs it was determined that In specific circumstances involving multiple steps, a rack sequencing error may occur. This will result in a mismatch between the sample ID and the test result reported for all subsequent sample racks in that run.
Cause as FDA categorized it: Software design · Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB)
Published research
The most relevant PubMed records for "ImmunoCAP Specific IgE"[tiab]. The summary above synthesizes these.
- Occupational asthma induced by fish exposure.
Añibarro B, Feijoo L, de Las Cuevas N, et al. · Occup Med (Lond) · 2023Case Reports
- ImmunoCAP Specific IgE test: an objective tool for research and routine allergy diagnosis.
Johansson SG · Expert Rev Mol Diagn · 2004
- Tropomyosin-based cross-reactivity and asymptomatic shellfish sensitization in patients with perennial allergy.
Hollstein MM, Schuppe MC, Hahn KK, et al. · Front Allergy · 2025
- Fish allergy tolerance 16 months after diagnosis.
Okamoto M, Takafuji S, Inoue S, et al. · Allergol Immunopathol (Madr) · 2021
- Comparison of the new RIDA qLine Allergy multiparameter immunoblot and the ImmunoCAP Specific IgE test for the identification of clinically relevant food and aeroallergen allergies.
Hahn KK, Schuppe MC, Hollstein MM, et al. · Front Allergy · 2024
- [A VALIDATION STUDY OF THE IMPROVED PRODUCT FOR MEASURING JAPANESE CYPRESS POLLEN-SPECIFIC IgE (THERMO SCIENTIFICࡊ ImmunoCAPࡊ ImmunoCAP JAPANESE CYPRESS POLLEN-SPECIFIC IgE)].
Yonekura S, Okamoto Y, Nakayama S · Arerugi · 2018
- Anisakis sensitization in different population groups and public health impact: A systematic review.
Mazzucco W, Raia DD, Marotta C, et al. · PLoS One · 2018Systematic Review
- Acquisition of tolerance to egg and peanut in African food-allergic children with atopic dermatitis.
Gray CL, Levin ME, Du Toit G · S Afr Med J · 2019
- Vespa velutina nigrithorax venom allergy: inhibition studies approach for the choice of specific immunotherapy.
Grossi V, Severino M, Massolo A, et al. · Eur Ann Allergy Clin Immunol · 2023
- Food dependant exercise induced anaphylaxis a retrospective study from 2 allergy clinics in Colombo, Sri Lanka.
de Silva NR, Dasanayake WM, Karunatilleke C, et al. · Allergy Asthma Clin Immunol · 2015Case Reports
- Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort.
Schlehofer B, Siegmund B, Linseisen J, et al. · Allergy · 2011Multicenter Study, Research Support, Non-U.S. Gov't
- The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy.
Maloney JM, Rudengren M, Ahlstedt S, et al. · J Allergy Clin Immunol · 2008Evaluation Study, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code DHB.
- NOVEOS Specific IgE (sIgE)Hycor Biomedical · 510(k) 2026
- Immulite 2000 3GALLERGY Specific Ige Assay KitSiemens Healthcare Diagnostics, Inc. · 510(k) 2012
- Noveos Immunoanalyzer SystemHycor Biomedical · 510(k) 2022
- ImmunoCAP Allergen d202, Allergen component rDer p 1,House dust mitePhadia AB · 510(k) 2016
- Immulite 2000 3GALLERGY Specific Ige Assay Kit, Model L2KUN6Siemens Medical Solutions Diagnostics · 510(k) 2011
- Immulite 2000 Allergen-Specific IgeDiagnostic Products Corp. · 510(k) 2002
- IMMULITE 2000 3gAllergy Specific IgE VantageSiemens Healthcare Diagnostics Products, Ltd. · 510(k) 2026
- ImmunoCAP Allergen f433Phadia AB · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.